Molina Healthcare, Inc. (MOH)
323.83 USD +11.94 (+3.83%) Volume: 0.83M
Boosting a robust performance, Molina Healthcare, Inc.’s stock price surges to 323.83 USD, marking a significant trading session increase of +3.83%. With a strong trading volume of 0.83M, the healthcare giant’s stock holds an impressive YTD percentage change of +11.26%, reflecting its unwavering appeal to investors.
Latest developments on Molina Healthcare, Inc.
Molina Healthcare has been making headlines recently with a series of key events leading up to today’s stock price movements. The company has announced the dates for its first quarter 2025 earnings release and conference call, generating anticipation among investors. Insider activity has also been notable, with Maurice Hebert acquiring $799K in Molina Healthcare stock and EVP making a significant purchase of $2.87M. Wells Fargo’s recent upgrade of Molina Healthcare to overweight from equal weight, along with a price target adjustment to $372 from $295, has further influenced the stock price. President & CEO’s purchase of $19.43M in stock and other insider moves signal confidence in the company’s future, while analyst James Woys’ bullish stance and Jeff D Barlow’s optimism in purchasing $3.77M in stock reflect positive sentiment among key stakeholders.
Molina Healthcare, Inc. on Smartkarma
Analysts on Smartkarma have been covering Molina Healthcare, a company that operates in the Managed Medicaid market, offering services to low-income individuals on behalf of state governments. Value Investors Club published a research report highlighting Molina’s successful business model in effectively managing Medicaid programs while minimizing risk for state administrators. The report, originally published 3 months ago, emphasized Molina’s advantage in the competitive landscape of Managed Medicaid.
Another research report by Baptista Research focused on Molina Healthcare‘s recent earnings report for the third quarter of 2024. Despite facing challenges such as upward pressure on medical costs, Molina Healthcare reported adjusted earnings per share of $6.01 on $9.7 billion of premium revenue. The report highlighted Molina Healthcare‘s robust adjusted pre-tax margin of 4.5%, showcasing a balanced business portfolio. Analysts at Baptista Research discussed the six biggest factors impacting Molina Healthcare‘s performance in 2025 and beyond in their insightful analysis.
A look at Molina Healthcare, Inc. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Molina Healthcare shows a positive long-term outlook. With high scores in Growth, Resilience, and Momentum, the company is positioned for continued success in the managed care industry. Molina Healthcare‘s focus on providing health care services to low-income families and individuals through Medicaid and other programs highlights its commitment to serving vulnerable populations.
Although Molina Healthcare‘s Dividend score is lower, its overall Value score indicates a solid investment opportunity. With health plans in multiple states and primary care clinics in key regions, Molina Healthcare is well-positioned to continue its growth and impact in the healthcare sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
